-
Uncategorized3 weeks agoSTAT+: Canadian medical societies lack sufficient conflict-of-interest policies, study finds
Most Canadian medical societies lack comprehensive policies governing conflicts of interest, and many existing policies are generally fragmented and narrow in scope, according to a new...
-
Uncategorized3 weeks agoSTAT+: At a time of tumult at FDA, a former commissioner is hopeful it’s on a better path
With the Food and Drug Administration facing upheaval and in the aftermath of a series of high-profile exits, former commissioner David Kessler sees an inflection point...
-
Uncategorized3 weeks agoBioMarin drug acquired in buyout misses goal in rare disease study
Tested in a condition known as ENPP1 deficiency, the treatment failed a trial goal that’s important to regulators, spurring doubts about its approval prospects.
-
Uncategorized3 weeks ago
The state of consumer health
On Thursday, the Health Tech team led a series of conversations at the Financial Times’ US Pharma and Biotech Summit, held in collaboration with Endpoints News....
-
Uncategorized3 weeks ago
Relay doubles the bar, outpacing Novartis with a 60% response in rare disease
Analysts are extremely encouraged by Phase 2 trial results for Relay Therapeutics’ PI3KA inhibitor in treating vascular malformations (VM), prompting the biotech to eye a potential...
-
Uncategorized3 weeks ago
Takeda cuts send layoffs soaring in May, rising year over year
Far fewer companies are letting employees go so far in 2026 compared to 2025, but the number of people affected is trending up, especially this month,...
-
Uncategorized3 weeks ago
Full-Life Technologies raises $150M; Quince’s reboot with pulmonary drug
Plus, news about Accro Bioscience, Hansa Biopharma, Shanghai Best-Link Bioscience and UCB. Full-Life Technologies gets $150M: The radiotherapy company has raised $110 million in a Series...
-
Uncategorized3 weeks agoSTAT+: Dexcom CEO hints at future uses for CGM
You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your...
-
Uncategorized3 weeks agoAdvances in genomics for drug discovery
DDW Editor Reece Armstrong speaks to Michelle Carlson about overall advances in genomics and the integration of emerging technologies to create more drug discovery and development opportunities. RA: How...
-
Uncategorized3 weeks agoSTAT+: A new ranking of pharma companies by R&D performance
Good morning. I’m feeling jealous of my colleagues who get to enjoy some good weather today in San Francisco for our Breakthrough West Summit. The need-to-know...
FDA imposes import alert on Indian plant after inspectors flag GMP failings
